PAHC FY 2020 Earnings Report — Phibro Animal Health Corporation Revenue & Financial Results | Market Cap Arena

Phibro Animal Health CorporationPAHC

FY 2020 Earnings

Reported August 26, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$800M	—	$828M	—	-3.3%
Op. Income	$69M	—	$73M	—	-5.6%
Gross Margin	32.1%	—	32.0%	—	0.1pp
Net Margin	4.2%	—	6.6%	—	-2.4pp
EPS (Diluted)	$0.83	—	$1.35	—	-38.5%
Free Cash Flow	$25M	—	$17M	—	46.4%

Revenue Flow

Item	Amount
REVENUE	$800M
Cost of Revenue	$543M
GROSS PROFIT	$257M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$188M
Other Expenses	$0
Operating Expenses	$188M
Cost & Expenses	$731M
OPERATING INCOME	$69M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$14M
INCOME BEFORE TAX	$56M
Income Tax Expense	$22M
Net Income from Continuing Ops	$34M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$34M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$34M
D&A	$32M
EBIT	$69M
EBITDA	$102M
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$800M
Cost of Revenue	$543M
GROSS PROFIT	$257M
R&D Expenses	$0
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$188M
Other Expenses	$0
Operating Expenses	$188M
Cost & Expenses	$731M
OPERATING INCOME	$69M
Interest Income	$2M
Interest Expense	$14M
Other Income/Expenses	-$14M
INCOME BEFORE TAX	$56M
Income Tax Expense	$22M
Net Income from Continuing Ops	$34M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$34M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$34M
D&A	$32M
EBIT	$69M
EBITDA	$102M
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$34M
Depreciation & Amortization	$32M
Stock-Based Compensation	$2M
Deferred Income Tax	$8M
Other Non-Cash Items	-$3M
Change in Working Capital	-$14M
OPERATING CASH FLOW	$59M
Capital Expenditure	-$34M
Acquisitions (Net)	-$55M
Purchases of Investments	-$80M
Sales/Maturities of Investments	$49M
Other Investing Activities	-$35M
NET CASH FROM INVESTING	-$120M
Net Debt Issuance	$60M
Common Stock Repurchased	$0
Common Dividends Paid	-$19M
Other Financing Activities	$0
NET CASH FROM FINANCING	$41M
FREE CASH FLOW	$25M
Net Change in Cash	-$21M

Balance Sheet

Item	Amount
Cash & Equivalents	$36M
Short-Term Investments	$55M
Net Receivables	$127M
Inventory	$197M
Other Current Assets	$37M
TOTAL CURRENT ASSETS	$452M
PP&E (Net)	$171M
Goodwill	$53M
Intangible Assets	$71M
Long-Term Investments	$10M
Tax Assets	$11M
Other Non-Current Assets	$16M
TOTAL NON-CURRENT ASSETS	$332M
TOTAL ASSETS	$784M
Account Payables	$66M
Short-Term Debt	$19M
Deferred Revenue	$0
Other Current Liabilities	$47M
TOTAL CURRENT LIABILITIES	$157M
Long-Term Debt	$368M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$12M
Other Non-Current Liabilities	$41M
TOTAL NON-CURRENT LIABILITIES	$439M
TOTAL LIABILITIES	$596M
Common Stock	$4.0K
Additional Paid-In Capital	$136M
Retained Earnings	$183M
Treasury Stock	$0
Accum. Other Comp. Income	-$130M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$188M
Minority Interest	$0
TOTAL EQUITY	$188M
TOTAL LIABILITIES & EQUITY	$784M
Total Debt	$411M
Net Debt	$374M